Quick Takeaways
- IMDX - Insight Molecular Diagnostics Inc. financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q1 2026.
- Headline metric: Return On Equity 230%.
- Info
- Insider Trading
- Financials
- Holders
Insight Molecular Diagnostics Inc. financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2026.
- Symbol
- IMDX on Nasdaq
- Location
- Nashville, TN
- Fiscal year end
- 31 December
- Latest financial report
- 26 Mar 2026
Shareable Research Card
IMDX - Insight Molecular Diagnostics Inc. Financial Facts
IMDX - Insight Molecular Diagnostics Inc. has a source-backed company facts page for reviewing reported financial metrics, periods, and linked metric histories.
Start with the latest metric summary, then open metric histories or cross-company rankings to compare the same SEC-backed facts.
- Context
- Latest metrics period: Q1 2026
- Latest reported value
- Return On Equity 230%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.
What Changed
- Return On Equity YoY change: <span class="text-red-600">-116%</span>.
- Most recent SEC facts end date: 19 Mar 2026.
Why This Matters
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Every metric card links to a deeper SEC-backed history page for verification.
Source Evidence
Based on latest 10-Q/10-K
See Original Filing
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.
Latest SEC snapshot (2026-03-19) highlights Return On Equity 229.6%, Return On Assets -165.1%, and Operating Margin -1260.8%.
Compare This Company Through SEC-backed Metrics
Use these links to compare IMDX - Insight Molecular Diagnostics Inc. against other SEC filers on the same metric, then verify the company history from the paired facts page.
Revenues YoY
Latest value: 116%
NetIncomeLoss YoY
Latest value: 17%
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
77.2/100
Balanced Confidence medium
Return On Equity
230%
Metric score 100.0/100
Return On Assets
-165%
Metric score 0.0/100
Financial Health
- Current Ratio
- 1.27x
- Quick Ratio
- 1.05x
Strengths
Return On Equity, Current Ratio, and Quick Ratio
Watchpoints
Return On Assets and Operating Margin
Key metrics snapshot
Return On Equity
230%
YoY: -116%
Industry median: -23% (n=21)
Return On Assets
-165%
YoY: +50%
Industry median: -41% (n=21)
Operating Margin
-1261%
YoY: -61%
Industry median: -69% (n=16)
Current Ratio
1.27x
YoY: -22%
Industry median: 2.56x (n=21)
Quick Ratio
1.05x
YoY: -25%
Industry median: 1.22x (n=18)
Revenues YoY
116%
YoY:
Industry median: -1.2% (n=17)
NetIncomeLoss YoY
17%
YoY:
Industry median: 13% (n=21)
Profitability
| Metric | Latest value | YoY change |
|---|---|---|
| Return On Equity | 230% | -116% |
| Return On Assets | -165% | +50% |
| Operating Margin | -1261% | -61% |
Financial Health
| Metric | Latest value | YoY change |
|---|---|---|
| Current Ratio | 1.27x | -22% |
| Quick Ratio | 1.05x | -25% |
Growth
| Metric | Latest value | YoY change |
|---|---|---|
| Revenues YoY | 116% | |
| NetIncomeLoss YoY | 17% |
Share Metrics
| Metric | Latest value | YoY change |
|---|---|---|
| Entity Common Stock, Shares Outstanding | 32,167,978 | +12% |
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- TTM Operating Income / TTM Revenues
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- TTM Revenues YoY
- TTM Net Income YoY